Strides Pharma Science Ltd
STARStrides Pharma Science Ltd
STARPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-128.73 | 4.18 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast from 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 2,961.59 | 3,097.80 | 3,534.85 | 2,545.66 | 2,909.44 | 3,518.84 | 3,259.23 | 3,935.44 | 4,145.05 | 4,145.05 | ||||||||||
Raw Materials | 1,612.38 | 1,432.25 | 1,286.65 | 1,189.20 | 1,167.29 | 1,686.50 | 1,407.04 | 1,629.55 | 3,672.64 | 3,672.64 | ||||||||||
Power & Fuel Cost | 77.18 | 33.87 | 51.33 | 54.39 | 64.49 | 64.58 | 71.54 | 85.82 | ||||||||||||
Employee Cost | 357.70 | 419.16 | 434.05 | 329.44 | 442.56 | 550.15 | 646.91 | 732.02 | ||||||||||||
Selling & Administrative Expenses | 323.35 | 339.47 | 409.34 | 276.20 | 338.51 | 473.78 | 577.98 | 526.31 | ||||||||||||
Operating & Other expenses | 154.11 | 54.45 | 313.14 | 196.74 | 525.25 | 98.10 | 798.52 | 724.97 | ||||||||||||
EBITDA | 436.87 | 818.60 | 1,040.34 | 499.69 | 371.34 | 645.73 | -242.76 | 236.77 | 472.41 | 472.41 | ||||||||||
Depreciation/Amortization | 131.25 | 126.15 | 154.04 | 117.39 | 173.70 | 206.29 | 233.01 | 243.25 | 220.68 | 220.69 | ||||||||||
PBIT | 305.62 | 692.45 | 886.30 | 382.30 | 197.64 | 439.44 | -475.77 | -6.48 | 251.73 | 251.72 | ||||||||||
Interest & Other Items | 168.17 | 183.10 | 196.24 | 79.29 | 155.72 | 150.07 | 176.74 | 261.14 | 314.45 | 314.45 | ||||||||||
PBT | 137.45 | 509.35 | 690.06 | 303.01 | 41.92 | 289.37 | -652.51 | -267.62 | -62.72 | -62.73 | ||||||||||
Taxes & Other Items | 28.92 | 109.60 | 25.55 | -21.60 | 5.53 | 20.94 | -192.30 | -65.00 | 7.89 | 7.90 | ||||||||||
Net Income | 108.53 | 399.75 | 664.51 | 324.61 | 36.39 | 268.43 | -460.21 | -202.62 | -70.61 | -70.63 | ||||||||||
EPS | 14.10 | 43.28 | 71.89 | 35.67 | 4.06 | 29.95 | -51.29 | -22.50 | -7.76 | -7.82 | ||||||||||
DPS | 4.84 | 4.36 | 1.94 | 3.00 | 14.00 | 2.50 | 0.00 | 1.50 | 0.00 | 1.50 | ||||||||||
Payout ratio | 0.34 | 0.10 | 0.03 | 0.08 | 3.45 | 0.08 | 0.00 | — | 0.00 | -0.19 |
Company Updates
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Strides Pharma Science Ltd | -128.77 | 4.18 | — |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare STAR with any stock or ETFShareholdings
Promoter Holdings Trend
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 1.54%
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 2.14%
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Strides Pharma Science Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Quant Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.7421% | Percentage of the fund’s portfolio invested in the stock 1.17% | Change in the portfolio weight of the stock over the last 3 months -0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/119 (-1) |
Aditya Birla Sun Life Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.3730% | Percentage of the fund’s portfolio invested in the stock 0.99% | Change in the portfolio weight of the stock over the last 3 months 0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 45/91 (-18) |
Aditya Birla Sun Life Pure Value Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.5881% | Percentage of the fund’s portfolio invested in the stock 2.32% | Change in the portfolio weight of the stock over the last 3 months 0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/83 (+3) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 4, 2023
Dividend/Share
₹1.50
Ex DateEx Date
Aug 4, 2023
Cash Dividend
Ex DateEx DateAug 5, 2021
Dividend/Share
₹2.50
Ex DateEx Date
Aug 5, 2021
Cash Dividend
Ex DateEx DateJul 24, 2020
Dividend/Share
₹2.00
Ex DateEx Date
Jul 24, 2020
Cash Dividend
Ex DateEx DateAug 22, 2019
Dividend/Share
₹12.00
Ex DateEx Date
Aug 22, 2019
Cash Dividend
Ex DateEx DateJul 19, 2019
Dividend/Share
₹3.00
Ex DateEx Date
Jul 19, 2019
Strides Pharma Global, Singapore incorporates subsidiary in New Zealand
Strides Pharma Global, Singapore, a step-down wholly owned subsidiary of Strides Pharma Science has incorporated a company in New Zealand in the name of 'Strides Pharma New Zealand' on 26 July 2024. Strides New Zealand shall hold market authorizations for the products in New Zealand and shall also undertake trading in pharmaceutical products.Powered by Capital Market - Live
Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live
Lauras Labs, Strides Pharma: Top picks by Vinay Rajani to buy on July 18
Buy & Sell Ideas for June 19; check top stock picks by HDFC Securities
Strides Pharma Unit Receives US Regulatory Approval For Antidepressant Medication
Strides Pharma To Spin Off Contract Manufacturing Unit Into Stelis Biopharma
Strides Pharma Shares Hit 52-Week High As USFDA Tentative Nod To HIV Treatment Drug - News18
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 10.24%, vs industry avg of 8.96%
Increasing Market Share
Over the last 5 years, market share increased from 1.12% to 1.13%